Trials / Conditions / Stage IVB Pancreatic Cancer

Stage IVB Pancreatic Cancer

10 registered clinical trials studyying Stage IVB Pancreatic Cancer.

Status	Trial	Sponsor	Phase
Completed	Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer NCT04067960	Mayo Clinic	EARLY_Phase 1
Completed	Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer NCT03095781	Emory University	Phase 1
Completed	APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid NCT03087591	Wake Forest University Health Sciences	Phase 1
Completed	Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors NCT02897375	Emory University	Phase 1
Terminated	TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Pro NCT02650635	Mayo Clinic	Phase 1
Completed	Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Can NCT02451553	University of Washington	Phase 1
Completed	Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in P NCT02511821	City of Hope Medical Center	N/A
Completed	ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer NCT01825603	University of Nebraska	Phase 1
Unknown	Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer NCT00323583	Seattle Cancer Treatment and Wellness Center	Phase 2
Completed	Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer NCT00019006	National Cancer Institute (NCI)	Phase 1